Activos Circulantes Cambio Fecha
Agenus USD 78.81M 16.47M 2026-06
Alaunos Therapeutics USD 666K 304K 2026-06
Amgen USD 34.36B 598M 2026-09
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.29B 382.19M 2026-09
AstraZeneca USD 31.45B 3.48B 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Heron Therapeutics USD 209.11M 20.73M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Intrexon USD 23.72M 45.04M 2024-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Ligand Pharmaceuticals USD 608.23M 848.88M 2026-09
MacroGenics USD 295.08M 26.61M 2026-09
MannKind USD 240.48M 5.24M 2026-09
Merck USD 38.94B 2.26B 2026-09
Novartis USD 28.75B 1.4B 2026-09
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Thermo Fisher Scientific USD 25.62B 2.25B 2026-09
Veracyte USD 467.88M 106.9M 2026-09
Xencor USD 498.66M 24.55M 2026-09